ACRF provides grants for scientific equipment and other technologies as well as the establishment of capital works and facilities and national enterprises in support of all aspects of cancer research.
ACRF is a ‘seed’ funding body and is therefore interested in applications for larger scale research projects with value over and above the amount sought directly from ACRF. We expect applicants to leverage ACRF grants to secure any ‘gap’ funding and also to feature multi-disciplinary teams, collaborations and evidence of the translational impacts at a clinical level (with patients).
All applications are considered and assessed by our Medical Research Advisory Committee, a group of highly distinguished research scientists who are appointed by ACRF’s Board of Trustees.
The procedures of the Committee are similar to those employed by the National Health and Medical Research Council and include the assessment of applications by referees and independent expert assessors, as well as site visits and interviews of selected short-listed applicants.
The Committee’s recommendations for funding are reviewed and finalised by the ACRF Board of Trustees.
Our 2019 annual research grant round will open on Monday 5 March 2019 and close on Friday 10 May 2019.
The Grant Guidelines and Application Format documents will be updated following approval from our Board. Please use the 2018 versions below as a guide.
If you have any questions regarding ACRF grants process, please contact Cheryl Riddington on 1300 884 988 or criddington@acrf.com.au
Queensland researchers have conducted Australia’s first clinical trial using genetically engineered immune cells to make bone marrow tr...
An important component of the microscopic machinery that drives cell death has been identified by Walter and Eliza Hall Institute scien...